Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (131-140 of 407) with videos related to

Pageof 41
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 14, 2020
Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020Mark Jit, Thibaut Jombart, Emily S Nightingale, et al.
Sexually Transmitted Infections|January 25, 2019
Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimatesKoh Jun Ong, Marta Checchi, Lorna Burns, et al.
BMC Medicine|April 10, 2023
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countriesSarwat Mahmud, Ranju Baral, Colin Sanderson, et al.
The Lancet. Global Health|July 20, 2023
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling studyMegan Auzenbergs, Han Fu, Kaja Abbas, et al.
Health Economics|November 7, 2017
Estimating the opportunity costs of bed-daysFrank G Sandmann, Julie V Robotham, Sarah R Deeny, et al.
Plos Medicine|January 20, 2026
The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling studyAyaka Monoi, Akira Endo, Simon R Procter, et al.
Vaccine|December 27, 2014
Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policyStéphane Verguet, Mira Johri, Shaun K Morris, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
A Scoping Review of Investment Cases for Vaccines and Immunization ProgramsSo Yoon Sim, Mark Jit, Dagna Constenla, et al.
The Lancet. Public Health|August 15, 2017
Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for EnglandDeborah Cromer, Albert Jan van Hoek, Anthony T Newall, et al.
BMC Infectious Diseases|July 2, 2013
Modelling the transmission of healthcare associated infections: a systematic reviewEsther van Kleef, Julie V Robotham, Mark Jit, et al.
Pageof 41

Showing results (131-140 of 407) with videos related to

Sort By:
Pageof 41
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 14, 2020
Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020Mark Jit, Thibaut Jombart, Emily S Nightingale, et al.
Sexually Transmitted Infections|January 25, 2019
Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimatesKoh Jun Ong, Marta Checchi, Lorna Burns, et al.
BMC Medicine|April 10, 2023
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countriesSarwat Mahmud, Ranju Baral, Colin Sanderson, et al.
The Lancet. Global Health|July 20, 2023
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling studyMegan Auzenbergs, Han Fu, Kaja Abbas, et al.
Health Economics|November 7, 2017
Estimating the opportunity costs of bed-daysFrank G Sandmann, Julie V Robotham, Sarah R Deeny, et al.
Plos Medicine|January 20, 2026
The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling studyAyaka Monoi, Akira Endo, Simon R Procter, et al.
Vaccine|December 27, 2014
Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policyStéphane Verguet, Mira Johri, Shaun K Morris, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
A Scoping Review of Investment Cases for Vaccines and Immunization ProgramsSo Yoon Sim, Mark Jit, Dagna Constenla, et al.
The Lancet. Public Health|August 15, 2017
Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for EnglandDeborah Cromer, Albert Jan van Hoek, Anthony T Newall, et al.
BMC Infectious Diseases|July 2, 2013
Modelling the transmission of healthcare associated infections: a systematic reviewEsther van Kleef, Julie V Robotham, Mark Jit, et al.
Pageof 41